The global pancreatic cancer treatment market is entering a period of rapid transformation driven by intensified research efforts, growing awareness of early diagnostic methods, and escalating investments in novel therapeutic modalities. Pancreatic cancer remains one of the most aggressive and hard-to-treat malignancies worldwide, characterized by late diagnosis, limited treatment options, and...